Vima LLC Takes $124,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vima LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 369 shares of the medical equipment provider’s stock, valued at approximately $124,000.

Several other institutional investors have also recently bought and sold shares of ISRG. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares in the last quarter. Headinvest LLC acquired a new position in Intuitive Surgical during the third quarter worth about $28,000. Able Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Stone House Investment Management LLC increased its stake in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.7 %

Shares of NASDAQ ISRG traded up $2.88 during trading hours on Friday, reaching $425.78. 940,996 shares of the stock traded hands, compared to its average volume of 1,163,301. The company has a market capitalization of $151.02 billion, a P/E ratio of 76.86, a price-to-earnings-growth ratio of 5.50 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $428.86. The company’s 50-day simple moving average is $392.70 and its two-hundred day simple moving average is $374.43.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.00 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, Director Mark J. Rubash sold 1,709 shares of the stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $380.00, for a total transaction of $649,420.00. Following the sale, the director now directly owns 16,051 shares of the company’s stock, valued at $6,099,380. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders have sold a total of 17,956 shares of company stock valued at $6,927,011 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. BTIG Research upped their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Citigroup upped their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Piper Sandler increased their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Finally, Stifel Nicolaus increased their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $403.67.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.